Danish Cardiovascular Screening Trial II
Launched by ODENSE UNIVERSITY HOSPITAL · May 9, 2019
Trial Information
Current as of May 22, 2025
Active, not recruiting
Keywords
ClinConnect Summary
The Danish Cardiovascular Screening Trial II is looking to improve heart health, especially for men who may have less access to healthcare due to their social situation. The goal of this trial is to find effective ways to lower the risk of heart and blood vessel diseases in men aged 60 to 64 living in certain areas of Denmark, like Funen, Silkeborg, and Vejle.
If you’re a man between 60 and 64 years old and live in one of these areas, you might be eligible to participate. Those who join the study can expect to undergo screenings that will help identify any potential heart health issues early on. This trial is currently recruiting participants, so if you or someone you know fits the criteria, it could be a great opportunity to contribute to important research aimed at improving cardiovascular health for everyone.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Men aged 60-64 living in the municipalities of Funen, Silkeborg, Vejle and surrounding municipailties
- Exclusion Criteria:
- • Men not aged 60-64
- • Men not living in the mentioned municipalities
- • Women
About Odense University Hospital
Odense University Hospital is a leading academic medical center located in Denmark, dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital is committed to enhancing patient outcomes and fostering collaboration among multidisciplinary teams. With a focus on translating scientific discoveries into practical applications, Odense University Hospital leverages its state-of-the-art facilities and expertise to conduct rigorous trials across various medical fields, ensuring adherence to the highest ethical and regulatory standards. Through these efforts, the hospital aims to contribute significantly to the global body of medical knowledge and improve the quality of care for patients both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vejle, , Denmark
Odense, , Denmark
Svendborg, , Denmark
Odense, Fyn, Denmark
Silkeborg, , Denmark
Patients applied
Trial Officials
Jes S Lindholt, PhD
Principal Investigator
Odense University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials